In the past week, CME stock has gone down by -0.14%, with a monthly gain of 4.95% and a quarterly surge of 10.98%. The volatility ratio for the week is 1.58%, and the volatility levels for the last 30 days are 1.40% for CME Group Inc The simple moving average for the last 20 days is 1.80% for CME stock, with a simple moving average of 5.15% for the last 200 days.
Is It Worth Investing in CME Group Inc (NASDAQ: CME) Right Now?
CME Group Inc (NASDAQ: CME) has a higher price-to-earnings ratio of 24.07x compared to its average ratio. CME has 36-month beta value of 0.56. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CME is 358.90M, and currently, short sellers hold a 1.08% ratio of that float. The average trading volume of CME on September 18, 2024 was 2.21M shares.
CME) stock’s latest price update
CME Group Inc (NASDAQ: CME) has seen a decline in its stock price by -0.16 in relation to its previous close of 218.53. However, the company has experienced a -0.14% decline in its stock price over the last five trading sessions. zacks.com reported 2024-09-17 that Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with BofA Securities repeating the rating for CME by listing it as a “Underperform.” The predicted price for CME in the upcoming period, according to BofA Securities is $177 based on the research report published on September 03, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see CME reach a price target of $187, previously predicting the price at $206. The rating they have provided for CME stocks is “Underweight” according to the report published on June 21st, 2024.
Barclays gave a rating of “Equal Weight” to CME, setting the target price at $222 in the report published on January 08th of the current year.
CME Trading at 6.05% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.00% of loss for the given period.
Volatility was left at 1.40%, however, over the last 30 days, the volatility rate increased by 1.58%, as shares surge +4.46% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.90% upper at present.
During the last 5 trading sessions, CME fell by -0.14%, which changed the moving average for the period of 200-days by +1.55% in comparison to the 20-day moving average, which settled at $214.78. In addition, CME Group Inc saw 3.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from Fitzpatrick Lynne, who sale 754 shares at the price of $216.99 back on Sep 15 ’24. After this action, Fitzpatrick Lynne now owns 13,261 shares of CME Group Inc, valued at $163,610 using the latest closing price.
Durkin Bryan T, the Director of CME Group Inc, sale 7,593 shares at $214.59 during a trade that took place back on Aug 30 ’24, which means that Durkin Bryan T is holding 55,607 shares at $1,629,382 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.63 for the present operating margin
- 0.83 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.1. Equity return is now at value 11.92, with 2.41 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.03. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 22.87.
Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.71. When we switch over and look at the enterprise to sales, we see a ratio of 13.91. The receivables turnover for the company is 9.67for trailing twelve months and the total asset turnover is 0.05.
Conclusion
To put it simply, CME Group Inc (CME) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
